Product Information
CETIRIZINE HCL 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0510 per EA under NDC 16571040110. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571040110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077829On Market Since
10/1/2009
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0510 per EA |
|---|---|
| All-time high | $0.0858 (Nov 13, 2019) |
| All-time low | $0.0382 (Nov 20, 2024) |
| 52-week high | $0.0510 |
| 52-week low | $0.0472 |
| Median price | $0.0557 |
| Average price | $0.0568 |
| Largest weekly change | +48.6% (May 22, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0510 per EA (NDC 16571040110), effective Jun 24, 2026.
How has the price of CETIRIZINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG TABLET has declined 22.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG TABLET has ranged from a low of $0.0382 (Nov 20, 2024) to a high of $0.0858 (Nov 13, 2019), with a median of $0.0557 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CETIRIZINE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures CETIRIZINE HCL 5 MG TABLET?
CETIRIZINE HCL 5 MG TABLET (NDC 16571040110) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification